Starten Sie Ihre Suche...


Durch die Nutzung unserer Webseite erklären Sie sich damit einverstanden, dass wir Cookies verwenden. Weitere Informationen
Publikationen
Ergebnisse pro Seite:  10

Ebert, F; Thomann, M; Witt, B et al.

Evaluating long-term cellular effects of the arsenic species thio-DMAV: qPCR-based gene expression as screening tool

Journal of Trace Elements in Medicine and Biology. Bd. 37. 2016 S. 78-84


Fahrer, J.

Food-borne carcinogens

Schwab M. (Hrsg). Encyclopaedia of Cancer. Berlin-Heidelberg: Springer Verlag 2016


Krumm, A.; Barckhausen, C.; Kuecuek, P. et al.

HDAC1/HDAC2/HDAC3 mediated RAD51 and FANCD2 expression contribute to the resistance of melanoma cells to alkylating chemotherapeutics

ONCOLOGY RESEARCH AND TREATMENT. Bd. 39. 2016 S. 150-150



Christmann, M.; Kaina, B.

MGMT - A critical DNA repair gene target for chemotherapy resistance

Kelley M.R., Fishel M.L. (Hrsg). DNA Repair in Cancer Therapy; Molekular Targets and Clinical Applications. Academic Press Elsevier Inc. 2016


Switzeny, Olivier J.; Christmann, Markus; Renovanz, Mirjam et al.

MGMT promoter methylation determined by HRM in comparison to MSP and pyrosequencing for predicting high-grade glioma response

CLINICAL EPIGENETICS. Bd. 8. 2016


Mikhed, Yuliya; Fahrer, Joerg; Oelze, Matthias et al.

Nitroglycerin induces DNA damage and vascular cell death in the setting of nitrate tolerance

BASIC RESEARCH IN CARDIOLOGY. Bd. 111. H. 4. 2016


Waisman, Ari; Hoevelmeyer, Nadine; Diefenbach, Andreas et al.

Past, present and future of immunology in Mainz

CELLULAR IMMUNOLOGY. Bd. 308. 2016 S. 1-6


Zahnreich, Sebastian; Ebersberger, Anne; Karle, Heiko et al.

Quantification of Radiation Biomarkers in Leukocytes of Breast Cancer Patients Treated with Different Modalities of 3D-CRT or IMRT

RADIATION RESEARCH. Bd. 186. H. 5. 2016 S. 508-519


Sonnemann, Juergen; Kahl, Melanie; Siranjeevi, Priyanka M. et al.

Reverse chemomodulatory effects of the SIRT1 activators resveratrol and SRT1720 in Ewing's sarcoma cells: resveratrol suppresses and SRT1720 enhances etoposide- and vincristine-induced anticancer activity

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. Bd. 142. H. 1. 2016 S. 17-26